6331 – Coxiella burnetii infection (Q fever)

DBQ: Link to Index of DBQ/Exams by Disability for DC 6331

Definition

Q fever is a bacterial infection caused by Coxiella burnetii. It's a zoonotic disease, meaning it can be transmitted from animals to humans, primarily through inhalation of contaminated dust or aerosols from infected animals like cattle, sheep, and goats. While many infections are asymptomatic or mild, acute and chronic forms can occur, with chronic cases potentially leading to severe complications like endocarditis. 

Etiology

Q fever is a zoonotic disease caused by the gram-negative, obligate intracellular bacterium Coxiella burnetii. This bacterium is classified within the family Coxiellaceae. While initially classified alongside rickettsiae due to shared characteristics like obligate intracellular growth, phylogenetic analyses have since reclassified C. burnetii into the gamma subdivision of the Proteobacteria, placing it closer to Legionella and Francisella species than to Rickettsia. 

1. Reservoirs

C. burnetii infects a wide variety of animals, including mammals, birds, reptiles, and arthropods. However, the primary reservoirs for human infection are domestic ruminants, namely cattle, sheep, and goats. Other potential reservoirs include pets (especially dogs and cats), and various wildlife species. Interestingly, animals infected with C. burnetii often remain asymptomatic. 

2. Transmission

Humans primarily acquire Q fever through inhalation of aerosolized bacteria. These contaminated aerosols are generated from the feces, urine, milk, and birth products (placenta and amniotic fluid) of infected animals. The bacterium's resistance to environmental factors like heat and drying allows it to survive for extended periods in dust and aerosols, which can be carried long distances by wind. 

Less common modes of transmission include:

• Ingestion of contaminated raw (unpasteurized) milk or dairy products.
• Tick bites from infected ticks.
• Direct contact with infected tissues (e.g., in slaughterhouse workers or veterinarians).
• Rarely, human-to-human transmission has been reported via exposure to the placenta of an infected woman or through blood transfusions. 

3. Pathogenesis

C. burnetii is an obligate intracellular pathogen, meaning it can only replicate inside host cells, particularly monocytes and macrophages. The bacterium has a unique strategy for survival and replication: it resides and multiplies within the phagolysosome, an acidic compartment inside the host cell. This is unusual because the low pH and hydrolytic enzymes within the phagolysosome normally degrade pathogens. However, C. burnetii has evolved mechanisms to not only survive this harsh environment, but also to require the acidic pH for its metabolic activity and replication. 

Key aspects of pathogenesis:

• Intracellular Survival: C. burnetii manipulates host cell processes, including the autophagy pathway, to maintain a favorable environment for replication within the phagolysosome. The bacterium uses a type IV secretion system (T4SS) to inject effector proteins into the host cell cytoplasm. This subverts cellular activities and facilitates bacterial growth and survival.
• Phase Variation: C. burnetii can exist in two antigenic phases: Phase I and Phase II.
  • Phase I: Found in naturally infected hosts (humans and animals), possesses a full-length lipopolysaccharide (LPS), and is highly virulent and infectious.
  • Phase II: Arises from repeated passage in cell cultures or embryonated eggs, lacks the full-length LPS, and is avirulent.
  • This phase variation is important in diagnosing Q fever. Antibodies against phase I are characteristic of chronic infection, whereas antibodies against phase II are associated with acute infection. 

The development of Q fever can be influenced by host factors, including age, sex, and immune status. Individuals with pre-existing heart valve disease, vascular grafts, or aneurysms, pregnant women, and immunocompromised persons are at higher risk for chronic Q fever.

Signs & Symptoms

Q fever, caused by the bacterium Coxiella burnetii, presents with a wide range of symptoms, from mild flu-like illness to severe, life-threatening complications. Approximately half of infected individuals experience symptoms, typically appearing 2-3 weeks after exposure. 

Acute Q fever

Acute Q fever often manifests with a sudden onset of symptoms similar to the flu. These may include: 

• Fever: Often high, reaching up to 104-105°F (40-40.6°C).
• Headache: Can be severe and retro-orbital (behind the eyes).
• Chills or Sweats: Chills and sweating are common.
• Muscle Aches (Myalgia): Muscle pain and aches are frequent symptoms.
• Fatigue (Tiredness): A general feeling of weakness and exhaustion.
• Cough: Often non-productive (dry).
• Gastrointestinal Symptoms: Nausea, vomiting, diarrhea, stomach pain, or loss of appetite can occur.
• Chest Pain: May be present, especially with pneumonia.
• Sore Throat: Can be an accompanying symptom.
• Confusion: May occur in some cases.
• Weight Loss: Can be a lasting symptom. 

Severe acute Q fever

In some cases, acute Q fever can lead to more serious complications, including:

• Pneumonia: Infection of the lungs.
• Hepatitis: Inflammation of the liver.
• Endocarditis: Inflammation of the lining of the heart cavity or heart valves (more commonly seen in chronic Q fever, but can occur acutely).
• Neurological Manifestations: Rarely, Q fever can cause inflammation of the brain (encephalitis), its covering (meningitis), or the spinal cord (myelitis). 

Chronic Q fever

A small percentage (less than 5%) of individuals infected with Coxiella burnetii develop chronic Q fever, which can occur months or even years after the initial infection, even if the acute phase was asymptomatic. Chronic Q fever is a more serious condition and often involves the heart. Common symptoms include: 

• Low-grade fever: May be persistent.
• Night Sweats: Sweating excessively during sleep.
• Fatigue: Often severe and debilitating.
• Shortness of Breath: Particularly if heart complications are present.
• Weight Loss: Unexplained weight loss.
• Swelling of Legs or Feet: May indicate heart problems. 

The most frequent manifestation of chronic Q fever is endocarditis, an inflammation of the heart valves. This can lead to serious heart problems and even be fatal if left untreated. Other less common manifestations of chronic Q fever include chronic hepatitis, bone infections (osteomyelitis), vascular infections, and pulmonary infections. 

Tests

Diagnosing Q fever involves a combination of clinical suspicion, considering patient history and symptoms, and confirmatory laboratory testing. 

Here are the key tests used for diagnosing Q fever:

1. Serology

Serological tests are the most common way to diagnose Q fever, detecting antibodies produced by the body in response to the infection. 

• Indirect Immunofluorescence Assay (IFA): This is the gold standard for Q fever diagnosis.
  • It detects specific IgG and IgM antibodies against the two phases of C. burnetii (Phase I and Phase II).
  • Acute infection: A fourfold increase in Phase II IgG antibody concentration indicates a diagnosis. Phase II IgM antibodies are also detected in acute cases.
  • Chronic infection: Elevated Phase I IgG antibody titers are characteristic, often exceeding Phase II titers.
  • Limitations: IFA can be subjective and labor-intensive. Antibody tests may be negative early in the illness (first 15 days).
• Enzyme-Linked Immunosorbent Assay (ELISA): ELISA is another serological method used for Q fever diagnosis.
  • It is more economical and can screen more samples.
  • It can detect both IgM and IgG antibodies and differentiate between Phase I and Phase II antibodies, similar to IFA.
• Complement Fixation Test (CFT): This test checks if the body has produced antibodies to C. burnetii.
  • It is less sensitive than IFA, especially in detecting early IgM responses. 

2. Molecular detection (PCR)

PCR (Polymerase Chain Reaction) tests detect the DNA of C. burnetii directly in clinical specimens. 

• Usefulness: PCR is particularly helpful in the early acute phase of infection (first week of illness) before antibodies are fully developed. It's recommended to combine PCR with serological testing for a definitive diagnosis in the early stages.
• Specimens: PCR can be performed on whole blood, serum, or tissue biopsies.
• Limitations: Sensitivity decreases significantly after doxycycline treatment. A negative PCR result does not rule out Q fever, and treatment should not be withheld based on a negative PCR alone. 

3. Culture

Culturing C. burnetii is not routinely recommended for diagnosis. 

• Difficult and hazardous: It requires specialized laboratories with Biosafety Level 3 (BSL-3) containment because the bacteria is highly infectious.
• Time-consuming: The process is difficult and takes a long time.
• Specialized labs: Only specialized labs, like the CDC can perform this test. 

Important considerations

• Clinical suspicion is crucial: Because antibody tests may be negative in the early stages, healthcare providers often start treatment based on clinical suspicion, patient history (including animal exposure), and symptoms.
• Acute vs. chronic infection: Different testing strategies and interpretations are needed to distinguish between acute and chronic Q fever.
• Chronic Q fever diagnosis: Chronic Q fever is confirmed by persistently elevated Phase I IgG antibody titers and the identification of a focus of infection, such as endocarditis.
• Follow-up testing: Multiple samples taken over time may be necessary to confirm a diagnosis, especially when seroconversion or a significant rise in antibody titers is being sought. 

Treatment

Q fever, caused by the bacterium Coxiella burnetii, can manifest in both acute and chronic forms, each with specific treatment recommendations. 

Acute Q fever treatment

• First-line treatment: Doxycycline is the recommended antibiotic for most adults with acute Q fever. It is effective in shortening the duration of the illness. Treatment typically lasts 14 days.
• Treatment in specific populations:
  • Pregnant women: Trimethoprim/sulfamethoxazole (TMP-SMX) is recommended throughout pregnancy.
  • Children: Treatment varies depending on age and illness severity. Doxycycline is often used, even in children under 8 years. The CDC advises that the benefits outweigh the potential risk of dental staining.
• Alternative Treatments: Alternatives like moxifloxacin, clarithromycin, TMP-SMX, and rifampin may be considered for individuals with doxycycline allergies. Consultation with an infectious disease specialist is preferred. 

Chronic Q fever treatment

• Standard Treatment: Chronic Q fever, particularly endocarditis, requires prolonged combination therapy. The CDC recommends a combination of doxycycline and hydroxychloroquine for at least 18 months.
• Monitoring and Duration: Treatment duration is based on serologic response and clinical improvement. Monitoring antibody titers (Phase I IgG) is important, with a titer of ≤ 1:200 indicating a likely cure.
• Surgical Intervention: Surgical replacement of valves may be needed for endocarditis, especially with prosthetic valves.
• Pregnancy and Chronic Q fever: No specific guidelines exist for chronic Q fever during pregnancy, but consultation with specialists is advised. Postpartum, doxycycline and hydroxychloroquine for 12 months are recommended for those with elevated antibody titers. 

Important Notes:

• Prompt diagnosis and treatment are essential to prevent severe complications, such as chronic Q fever.
• Treatment for acute Q fever should be started based on clinical suspicion before laboratory confirmation.
• Consulting with an infectious disease specialist is highly recommended, especially for chronic or complicated cases. 

Residuals

Residuals or long-term effects of a Coxiella burnetii infection (Q fever) can manifest in different ways, according to the CDC and Medscape: 

1. Chronic Q fever

• This more serious form can develop months or years after the initial infection, even if the person was initially asymptomatic.
• It's more likely in individuals with pre-existing heart valve issues, vascular defects, weakened immune systems, or those who were pregnant during the infection.
• The most common manifestation is endocarditis (inflammation of the heart valves or inner lining of the heart), which can be fatal if left untreated.
• Other potential manifestations include infections of blood vessels (aneurysms, vascular prostheses), bones (osteomyelitis), liver, and other organs.
• Chronic Q fever requires prolonged antibiotic treatment (often 18 months or more). 

2. Q fever fatigue syndrome (QFS)

• This involves persistent fatigue lasting months or years after the acute infection, even though the bacteria may have been cleared.
• Along with debilitating fatigue, individuals may experience muscle aches, joint pain, headaches, night sweats, and recurrent upper respiratory tract infections.
• It impacts health-related quality of life and can affect work and social participation.
• While the exact cause is unclear, it may involve immune system abnormalities. 

3. Other potential complications

• Pulmonary fibrosis: Scarring in the lungs.
• Acute Respiratory Distress Syndrome (ARDS): A severe lung injury.
• Heart failure.
• Pregnancy complications: Miscarriage, stillbirth, premature delivery, low birth weight.

Important notes:

• Long-term monitoring, especially for those at risk of chronic Q fever, is crucial and may include serological testing and echocardiography.
• Doxycycline is the recommended treatment for acute Q fever, according to the CDC, and a combination of doxycycline and hydroxychloroquine is typically used for chronic cases.
• Treatment for chronic Q fever can be complex and requires specialized medical care.